Artificial blood vessel
Artificial blood vessel

Artificial blood vessel Comprehensive Study by Application (Aortic Disease, Peripheral Artery Disease, Hemodialysis), Material Used (Natural Materials, Synthetic Polymers) Players and Region - Global Market Outlook to 2024

Artificial blood vessel Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 201 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Artificial blood vessel Market Overview:
Artificial vessels were earlier made by using tubes of glass and aluminum in that period, now the artificial vessels are made from synthetic polymers. Initially, when using donor vessels, arteriosclerosis occurred, and in other cases, donor arteries were rejected by the patient. This leads may lead to clotting, increased visits to the hospital, and risk of infection. More flexible and acceptable synthetic materials were then used as a focus on development. Artificial blood vessels are tubes made from synthetic (chemically produced) materials to restore blood circulation. Some of the key players profiled in the study are Humacyte Inc. (United States), W. L. Gore & Associates (United States), B. Braun Melsungen AG (Germany), Jotec GmbH (Germany), LeMaitre Vascular (United States), Perouse Medical (France) and Nicast (Israel).

On the basis of geography, the market of Artificial blood vessel has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Material Used, the sub-segment i.e. Natural Materials will boost the Artificial blood vessel market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Cases of Cardiovascular Disease
  • Rising Expenditure on Healthcare

Market Trend
  • Technology Development in Artificial Blood Vessel

Restraints
  • High Cost Related to Artificial Blood Vessel

Opportunities
  • Growing Infrastructural Development in Developing Countries

Challenges
  • The Artificial Materials Used So Far Are Not Fully Compatible With Body Tissue and the Blood Vessel Can Easily Become Blocked




The manufacturers are investing in research and development of effective and long-acting products with minor adverse effects. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies to increase their market share.

Target Audience:
Manufacturers of Artificial Blood Vessel, Suppliers of Artificial Blood Vessel, Wholesalers, Distributors and Retailers of Artificial Blood Vessel, Healthcare Industry, Regulatory Organization and Governmental Bodies

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Artificial blood vessel market on the basis of product [] , application [Aortic Disease, Peripheral Artery Disease and Hemodialysis], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Artificial blood vessel market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Artificial blood vessel industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Artificial blood vessel market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Application
  • Aortic Disease
  • Peripheral Artery Disease
  • Hemodialysis
By Material Used
  • Natural Materials
  • Synthetic Polymers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Cases of Cardiovascular Disease
      • 3.2.2. Rising Expenditure on Healthcare
    • 3.3. Market Challenges
      • 3.3.1. The Artificial Materials Used So Far Are Not Fully Compatible With Body Tissue and the Blood Vessel Can Easily Become Blocked
    • 3.4. Market Trends
      • 3.4.1. Technology Development in Artificial Blood Vessel
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial blood vessel, by Application, Material Used and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Artificial blood vessel (Value)
      • 5.2.1. Global Artificial blood vessel by: Application (Value)
        • 5.2.1.1. Aortic Disease
        • 5.2.1.2. Peripheral Artery Disease
        • 5.2.1.3. Hemodialysis
      • 5.2.2. Global Artificial blood vessel by: Material Used (Value)
        • 5.2.2.1. Natural Materials
        • 5.2.2.2. Synthetic Polymers
      • 5.2.3. Global Artificial blood vessel Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Artificial blood vessel (Price)
  • 6. Artificial blood vessel: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Humacyte Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. W. L. Gore & Associates (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Jotec GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. LeMaitre Vascular (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Perouse Medical (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nicast (Israel)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Artificial blood vessel Sale, by Application, Material Used and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Artificial blood vessel (Value)
      • 7.2.1. Global Artificial blood vessel by: Application (Value)
        • 7.2.1.1. Aortic Disease
        • 7.2.1.2. Peripheral Artery Disease
        • 7.2.1.3. Hemodialysis
      • 7.2.2. Global Artificial blood vessel by: Material Used (Value)
        • 7.2.2.1. Natural Materials
        • 7.2.2.2. Synthetic Polymers
      • 7.2.3. Global Artificial blood vessel Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Artificial blood vessel (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial blood vessel: by Application(USD Million)
  • Table 2. Artificial blood vessel Aortic Disease , by Region USD Million (2013-2018)
  • Table 3. Artificial blood vessel Peripheral Artery Disease , by Region USD Million (2013-2018)
  • Table 4. Artificial blood vessel Hemodialysis , by Region USD Million (2013-2018)
  • Table 5. Artificial blood vessel: by Material Used(USD Million)
  • Table 6. Artificial blood vessel Natural Materials , by Region USD Million (2013-2018)
  • Table 7. Artificial blood vessel Synthetic Polymers , by Region USD Million (2013-2018)
  • Table 8. South America Artificial blood vessel, by Country USD Million (2013-2018)
  • Table 9. South America Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 10. South America Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 11. Brazil Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 12. Brazil Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 13. Argentina Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 14. Argentina Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 15. Rest of South America Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 16. Rest of South America Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 17. Asia Pacific Artificial blood vessel, by Country USD Million (2013-2018)
  • Table 18. Asia Pacific Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 19. Asia Pacific Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 20. China Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 21. China Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 22. Japan Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 23. Japan Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 24. India Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 25. India Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 26. South Korea Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 27. South Korea Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 28. Taiwan Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 29. Taiwan Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 30. Australia Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 31. Australia Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 32. Rest of Asia-Pacific Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 34. Europe Artificial blood vessel, by Country USD Million (2013-2018)
  • Table 35. Europe Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 36. Europe Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 37. Germany Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 38. Germany Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 39. France Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 40. France Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 41. Italy Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 42. Italy Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 43. United Kingdom Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 44. United Kingdom Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 45. Netherlands Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 46. Netherlands Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 47. Rest of Europe Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 48. Rest of Europe Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 49. MEA Artificial blood vessel, by Country USD Million (2013-2018)
  • Table 50. MEA Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 51. MEA Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 52. Middle East Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 53. Middle East Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 54. Africa Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 55. Africa Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 56. North America Artificial blood vessel, by Country USD Million (2013-2018)
  • Table 57. North America Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 58. North America Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 59. United States Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 60. United States Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 61. Canada Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 62. Canada Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 63. Mexico Artificial blood vessel, by Application USD Million (2013-2018)
  • Table 64. Mexico Artificial blood vessel, by Material Used USD Million (2013-2018)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Artificial blood vessel: by Application(USD Million)
  • Table 73. Artificial blood vessel Aortic Disease , by Region USD Million (2019-2024)
  • Table 74. Artificial blood vessel Peripheral Artery Disease , by Region USD Million (2019-2024)
  • Table 75. Artificial blood vessel Hemodialysis , by Region USD Million (2019-2024)
  • Table 76. Artificial blood vessel: by Material Used(USD Million)
  • Table 77. Artificial blood vessel Natural Materials , by Region USD Million (2019-2024)
  • Table 78. Artificial blood vessel Synthetic Polymers , by Region USD Million (2019-2024)
  • Table 79. South America Artificial blood vessel, by Country USD Million (2019-2024)
  • Table 80. South America Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 81. South America Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 82. Brazil Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 83. Brazil Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 84. Argentina Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 85. Argentina Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 86. Rest of South America Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 87. Rest of South America Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 88. Asia Pacific Artificial blood vessel, by Country USD Million (2019-2024)
  • Table 89. Asia Pacific Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 90. Asia Pacific Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 91. China Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 92. China Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 93. Japan Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 94. Japan Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 95. India Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 96. India Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 97. South Korea Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 98. South Korea Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 99. Taiwan Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 100. Taiwan Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 101. Australia Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 102. Australia Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 103. Rest of Asia-Pacific Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 104. Rest of Asia-Pacific Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 105. Europe Artificial blood vessel, by Country USD Million (2019-2024)
  • Table 106. Europe Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 107. Europe Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 108. Germany Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 109. Germany Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 110. France Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 111. France Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 112. Italy Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 113. Italy Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 114. United Kingdom Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 115. United Kingdom Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 116. Netherlands Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 117. Netherlands Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 118. Rest of Europe Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 119. Rest of Europe Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 120. MEA Artificial blood vessel, by Country USD Million (2019-2024)
  • Table 121. MEA Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 122. MEA Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 123. Middle East Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 124. Middle East Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 125. Africa Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 126. Africa Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 127. North America Artificial blood vessel, by Country USD Million (2019-2024)
  • Table 128. North America Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 129. North America Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 130. United States Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 131. United States Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 132. Canada Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 133. Canada Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 134. Mexico Artificial blood vessel, by Application USD Million (2019-2024)
  • Table 135. Mexico Artificial blood vessel, by Material Used USD Million (2019-2024)
  • Table 136. Research Programs/Design for This Report
  • Table 137. Key Data Information from Secondary Sources
  • Table 138. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial blood vessel: by Application USD Million (2013-2018)
  • Figure 5. Global Artificial blood vessel: by Material Used USD Million (2013-2018)
  • Figure 6. South America Artificial blood vessel Share (%), by Country
  • Figure 7. Asia Pacific Artificial blood vessel Share (%), by Country
  • Figure 8. Europe Artificial blood vessel Share (%), by Country
  • Figure 9. MEA Artificial blood vessel Share (%), by Country
  • Figure 10. North America Artificial blood vessel Share (%), by Country
  • Figure 11. Global Artificial blood vessel share by Players 2018 (%)
  • Figure 12. Global Artificial blood vessel share by Players (Top 3) 2018(%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Humacyte Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 15. Humacyte Inc. (United States) Revenue: by Geography 2018
  • Figure 16. W. L. Gore & Associates (United States) Revenue, Net Income and Gross profit
  • Figure 17. W. L. Gore & Associates (United States) Revenue: by Geography 2018
  • Figure 18. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 19. B. Braun Melsungen AG (Germany) Revenue: by Geography 2018
  • Figure 20. Jotec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Jotec GmbH (Germany) Revenue: by Geography 2018
  • Figure 22. LeMaitre Vascular (United States) Revenue, Net Income and Gross profit
  • Figure 23. LeMaitre Vascular (United States) Revenue: by Geography 2018
  • Figure 24. Perouse Medical (France) Revenue, Net Income and Gross profit
  • Figure 25. Perouse Medical (France) Revenue: by Geography 2018
  • Figure 26. Nicast (Israel) Revenue, Net Income and Gross profit
  • Figure 27. Nicast (Israel) Revenue: by Geography 2018
  • Figure 28. Global Artificial blood vessel: by Application USD Million (2019-2024)
  • Figure 29. Global Artificial blood vessel: by Material Used USD Million (2019-2024)
  • Figure 30. South America Artificial blood vessel Share (%), by Country
  • Figure 31. Asia Pacific Artificial blood vessel Share (%), by Country
  • Figure 32. Europe Artificial blood vessel Share (%), by Country
  • Figure 33. MEA Artificial blood vessel Share (%), by Country
  • Figure 34. North America Artificial blood vessel Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Humacyte Inc. (United States)
  • W. L. Gore & Associates (United States)
  • B. Braun Melsungen AG (Germany)
  • Jotec GmbH (Germany)
  • LeMaitre Vascular (United States)
  • Perouse Medical (France)
  • Nicast (Israel)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation